Although P-gp is highly expressed in some gastric cancer patients, it was not related to the poor prognosis of patients who were treated with adriamycin and 5-fluorouracil therapy (Gürel et al., 1999; Choi et al., 2002). This evidence concerns the gene PGP and gastric cancer.